Multi-metric behavioral comparison of APPsw and P30IL models for Alzheimer's Disease: linkage of poorer cognitive performance to tau pathology in forebrain

被引:98
作者
Arendash, GW
Lewis, J
Leighty, RE
McGowan, E
Cracchiolo, JR
Hutton, M
Garcia, MF
机构
[1] Univ S Florida, Memory & Aging Res Lab, Tampa, FL 33620 USA
[2] Johnnie B Byrd Alzheimers Ctr, Tampa, FL 33620 USA
[3] Res Inst, Tampa, FL 33620 USA
[4] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA
关键词
Alzheimer's; APP; tau; transgenic; beta-amyloid; cognitive performance; NFT-containing neuron;
D O I
10.1016/j.brainres.2004.02.081
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
APPsw transgenic mice bearing the "Swedish" amyloid precursor protein (APP) mutation and JNPL3 transgenic mice bearing the P301L (Tau) mutation were compared to control non-transgenic (NT) mice in an extensive behavioral test battery administered between 5 and 8.5 months of age. APP mice were impaired in a variety of cognitive-based tasks prior to overt Abeta plaque development, making involvement of mutant APP overexpression and/or oligomeric Abeta assemblies most likely. Although Tau mice, as a group, were not impaired in any single behavioral measure, a collective assessment of behavioral measures through discriminant function analysis showed that Tau mice were impaired in overall behavioral (cognitive) performance. Moreover, correlation analyses involving Tau mice alone revealed linkage between poorer cognitive performance in all three water maze tasks and the number of neurofibrillary tangle (NFT)-containing neurons in neocortex and hippocampus. These findings indicate that: (1) APP mice show early and extensive cognitive impairment before evident Abeta deposition, and (2) the process or product of NFT formation in Tau mice is sufficient to deleteriously impact cognitive performance. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 41
页数:13
相关论文
共 34 条
[11]   Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse [J].
Gordon, MN ;
Holcomb, LA ;
Jantzen, PT ;
DiCarlo, G ;
Wilcock, D ;
Boyett, KW ;
Connor, K ;
Melachrino, J ;
O'Callaghan, JP ;
Morgan, D .
EXPERIMENTAL NEUROLOGY, 2002, 173 (02) :183-195
[12]   Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice [J].
Gordon, MN ;
King, DL ;
Diamond, DM ;
Jantzen, PT ;
Boyett, KV ;
Hope, CE ;
Hatcher, JM ;
DiCarlo, G ;
Gottschall, WPE ;
Morgan, D ;
Arendash, GW .
NEUROBIOLOGY OF AGING, 2001, 22 (03) :377-385
[13]   Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes [J].
Holcomb, L ;
Gordon, MN ;
McGowan, E ;
Yu, X ;
Benkovic, S ;
Jantzen, P ;
Wright, K ;
Saad, I ;
Mueller, R ;
Morgan, D ;
Sanders, S ;
Zehr, C ;
O'Campo, K ;
Hardy, J ;
Prada, CM ;
Eckman, C ;
Younkin, S ;
Hsiao, K ;
Duff, K .
NATURE MEDICINE, 1998, 4 (01) :97-100
[14]   Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits [J].
Holcomb, LA ;
Gordon, MN ;
Jantzen, P ;
Hsiao, K ;
Duff, K ;
Morgan, D .
BEHAVIOR GENETICS, 1999, 29 (03) :177-185
[15]   Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice [J].
Hsiao, K ;
Chapman, P ;
Nilsen, S ;
Eckman, C ;
Harigaya, Y ;
Younkin, S ;
Yang, FS ;
Cole, G .
SCIENCE, 1996, 274 (5284) :99-102
[16]   Characterization of learning and memory behaviors and the effects of metrifonate in the C57BL strain of mice [J].
Ikonen, S ;
Schmidt, BH ;
Riekkinen, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (02) :117-126
[17]   COMPREHENSIVE OBSERVATIONAL ASSESSMENT .IA. A SYSTEMATIC QUANTITATIVE PROCEDURE FOR ASSESSING BEHAVIORAL AND PHYSIOLOGIC STATE OF MOUSE [J].
IRWIN, S .
PSYCHOPHARMACOLOGIA, 1968, 13 (03) :222-&
[18]   Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease [J].
Kawarabayashi, T ;
Younkin, LH ;
Saido, TC ;
Shoji, M ;
Ashe, KH ;
Younkin, SG .
JOURNAL OF NEUROSCIENCE, 2001, 21 (02) :372-381
[19]   Progressive and gender-dependent cognitive impairment in the APPSW transgenic mouse model for Alzheimer's disease [J].
King, DL ;
Arendash, GW ;
Crawford, F ;
Sterk, T ;
Menendez, J ;
Mullan, MJ .
BEHAVIOURAL BRAIN RESEARCH, 1999, 103 (02) :145-162
[20]   Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months [J].
King, DL ;
Arendash, GW .
PHYSIOLOGY & BEHAVIOR, 2002, 75 (05) :627-642